Health Catalyst, Inc.

NasdaqGS:HCAT Voorraadrapport

Marktkapitalisatie: US$465.6m

Health Catalyst Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Health Catalyst has been growing earnings at an average annual rate of 14.9%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 15.3% per year.

Belangrijke informatie

14.9%

Groei van de winst

67.0%

Groei van de winst per aandeel

Healthcare Services Groei van de industrie1.7%
Inkomstengroei15.3%
Rendement op eigen vermogen-24.2%
Nettomarge-28.9%
Volgende winstupdate06 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets

Sep 24

Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Jul 17
Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Health Catalyst: Stellar Earnings Growth Projected

Jun 26

Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 12
Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Apr 04
Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

Mar 09

Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)

Feb 16

Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

Jan 27
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Dec 24
What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Dec 15
Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Oct 24
Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Jul 31
Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Jun 27
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Feb 22
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Dec 06
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Nov 03
Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate

Oct 14

Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer

Sep 07

Opbrengsten en kosten

Hoe Health Catalyst geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqGS:HCAT Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24299-8610862
31 Mar 24297-10611266
31 Dec 23296-11811169
30 Sep 23290-12411869
30 Jun 23285-14713170
31 Mar 23282-14813069
31 Dec 22276-13714469
30 Sep 22272-15114468
30 Jun 22265-14514367
31 Mar 22254-14714864
31 Dec 21242-15313262
30 Sep 21230-14712360
30 Jun 21216-13511257
31 Mar 21200-12610255
31 Dec 20189-1159654
30 Sep 20179-868952
30 Jun 20171-999052
31 Mar 20165-1818549
31 Dec 19155-2417946
30 Sep 19148-3047644
30 Jun 19141-2826941
31 Mar 19127-1907139
31 Dec 18113-1146638
31 Dec 1773-594128

Kwaliteitswinsten: HCAT is currently unprofitable.

Groeiende winstmarge: HCAT is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: HCAT is unprofitable, but has reduced losses over the past 5 years at a rate of 14.9% per year.

Versnelling van de groei: Unable to compare HCAT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: HCAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).


Rendement op eigen vermogen

Hoge ROE: HCAT has a negative Return on Equity (-24.21%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden